Dapagliflozina
Dapagliflozina (461432-26-8)
Dapagliflozin is the first approved SGLT2 inhibitor for the treatment of type II diabetes, which is used to improve glycemic control as an adjunct to dietary and exercise for adults with type II diabetes. Product Name: Dapagliflozin CAS No.: 461432-26-8 Assay: 99% Specification: CP, EP, In-house, as required Molecular Formula: C21H25ClO6 Molecular Weight: 408.88 Shelf Life: 2 Years Package: 25kg/drum
Dapagliflozina Tetraacetato (461432-25-7)
Dapagliflozin Tetraacetate can be used as intermediate in synthesis of Dapagliflozin, mainly used in laboratory research and industrial production process. Product Name: Dapagliflozin Tetraacetate CAS No.: 461432-25-7 Assay: 98% End Use: Dapagliflozin Molecular Formula: C29H33ClO10 Molecular Weight: 577.02 Shelf Life: 2 Years Package: 25kg/drum
1-Cloro-2-(4-etoxibenzil) -4-iodobenzeno (1103738-29-9)
1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene can be used as intermediate in synthesis of Dapagliflozin, mainly used in laboratory research and industrial production process. Product Name: 1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene CAS No.: 1103738-29-9 Assay: 98% End Use: Dapagliflozin Molecular Formula: C15H14ClIO Molecular Weight: 372.63 Shelf Life: 2 Years Package: 25kg/drum
5-bromo-2-cloro-4'-etoxidifenilmetano (461432-23-5)
5-bromo-2-chloro-4’-ethoxydiphenylmethane can be used as intermediate in synthesis of Dapagliflozin, mainly used in laboratory research and industrial production process. Product Name: 5-bromo-2-chloro-4'-ethoxydiphenylmethane CAS No.: 461432-23-5 Assay: 98% End Use: Dapagliflozin Molecular Formula: C15H14BrIO Molecular Weight: 325.63 Shelf Life: 2 Years Package: 25kg/drum